The metabolism and anti-atherogenic properties of HDL

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162

Effects of torcetrapib in patients at high risk for coronary events

Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139

Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

Barter, P., Gotto, A. M., LaRosa, J. C., Maroni, J., Szarek, M., Grundy, S. M., Kastelein, J. J. P., Bittner, V., & Fruchart, J.-C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064278 · Cited by 1,610

New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport

Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,104

Effect of Torcetrapib on the Progression of Coronary Atherosclerosis

Nissen, S. E., Tardif, J., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Rużyłło, W., Bachinsky, W., Lasala, G. P., & Tuzcu, E. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070635 · Cited by 968

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

COCKERILL, G. W., Rye, K., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1987 · Cited by 788

Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol

Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.

Badimón, J. J., Badimón, L., & Fuster, V. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114558 · Cited by 764

Endothelial and Antithrombotic Actions of HDL

Mineo, C., Deguchi, H., Griffin, J. H., & Shaul, P. W. (2006) · Circulation Research · doi:10.1161/01.res.0000225982.01988.93 · Cited by 663

Phospholipid Transfer Protein Is Expressed in Cerebrovascular Endothelial Cells and Involved in High Density Lipoprotein Biogenesis and Remodeling at the Blood-Brain Barrier

Manavalan, A. P. C., Kober, A. C., Metso, J., Lang, I., Becker, T. M., Hasslitzer, K., Zandl‐Lang, M., Fanaee‐Danesh, E., Pippal, J. B., Sachdev, V., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.499129 · Cited by 37

Long-term fasting improves lipoprotein-associated atherogenic risk in humans

Grundler, F., Plonné, D., Mesnage, R., Müller, D., Sirtori, C. R., Ruscica, M., & de Toledo, F. W. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02578-0 · Cited by 40

HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity

Kang, H.-Y., Song, J., & Cheng, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112622 · Cited by 36

High-Density Lipoprotein Proteomics: Identifying New Drug Targets and Biomarkers by Understanding Functionality

Gordon, S. M., Durairaj, A., Lu, J. L., & Davidson, W. S. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-009-0069-9 · Cited by 35

Targeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?

Barter, P. J., & Rye, K. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.07.021 · Cited by 35

Therapeutic Approaches to the Regulation of Metabolism of High-Density Lipoprotein

Zhang, B., Kawachi, E., Miura, S.-I., Uehara, Y., Matsunaga, A., Kuroki, M., & Saku, K. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-1584 · Cited by 34

LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea

Flores, R., Jin, X., Chang, J., Zhang, C., Cogan, D. G., Schaefer, E. J., & Kruth, H. S. (2019) · Biomolecules · doi:10.3390/biom9120785 · Cited by 34

Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels

Francone, O. L., Ishida, B. Y., de la Llera-Moya, M., Royer, L. J., Happe, C., Zhu, J. H., Chalkey, R. J., Schaefer, P. M., Cox, C. J., Burlingame, A. L., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m016527 · Cited by 32

The influence of major dietary fatty acids on insulin secretion and action

López, S., Bermúdez, B., Abia, R., & Muriana, F. J. G. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283346d39 · Cited by 32

Lower vitamin D intake is associated with low HDL cholesterol and vitamin D insufficiency/deficiency in Brazilian children

Filgueiras, M. D. S., Suhett, L. G., Silva, M. A., Rocha, N. P., & de Novaes, J. F. (2018) · Public Health Nutrition · doi:10.1017/s1368980018000204 · Cited by 32

Estimating the Effect of Aerobic Exercise Training on Novel Lipid Biomarkers: A Systematic Review and Multivariate Meta-Analysis of Randomized Controlled Trials

Wood, G., Taylor, E., Ng, V., Murrell, A., Patil, A., van der Touw, T., Wolden, M., Andronicos, N., & Smart, N. A. (2023) · Sports Medicine · doi:10.1007/s40279-023-01817-0 · Cited by 31

The Global Prevalence of Vitamin D Deficiency in the Elderly: A Meta-analysis

Meshkin, A., Badiee, F., Salari, N., Hassanabadi, M., Khaleghi, A. A., & Mohammadi, M. (2024) · Indian Journal of Orthopaedics · doi:10.1007/s43465-023-01089-w · Cited by 31

Novel Molecular Imaging of Atherosclerosis With Gallium-68-Labeled Apolipoprotein A-I Mimetic Peptide and Positron Emission Tomography

Kawachi, E., Uehara, Y., Hasegawa, K., Yahiro, E., Ando, S., Wada, Y., Yano, T., Nishikawa, H., Shiomi, M., Miura, S.-I., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-12-0736 · Cited by 31

Antioxidant compounds from Annona crassiflora fruit peel reduce lipid levels and oxidative damage and maintain the glutathione defense in hepatic tissue of Triton WR-1339-induced hyperlipidemic mice

Ramos, L. P. A., Justino, A. B., Tavernelli, N., Saraiva, A. L., Franco, R. R., de Souza, A. V., Silva, H. C. G., de Moura, F. B. R., Botelho, F. V., & Espíndola, F. S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112049 · Cited by 31

HDL-C: clinical equipoise and vascular endothelial function

Campbell, S., & Genest, J. J. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.13.17 · Cited by 30

Impaired HDL function in obese adolescents: Impact of lifestyle intervention and bariatric surgery

Matsuo, Y., Oberbach, A., Till, H., Inge, T. H., Wabitsch, M., Moß, A., Jehmlich, N., Völker, U., Müller, U., Siegfried, W., et al. (2013) · Obesity · doi:10.1002/oby.20538 · Cited by 33

Consenso de expertos sobre propuestas para la mejora del manejo de la dislipemia aterogénica

Núñez-Cortés, J. M., Pedro‐Botet, J., Brea-Hernando, Á., Rodríguez, Á. D., González‐Santos, P., Hernández‐Mijares, A., Mantilla, T., Pintó, X., & Simó, R. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.06.014 · Cited by 30

Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluid

Miller, N. E., Olszewski, W. L., Hattori, H., Miller, I. P., Kujiraoka, T., Oka, T., Iwasaki, T., & Nanjee, M. N. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00324.2012 · Cited by 30

Folded functional lipid-poor apolipoprotein A-I obtained by heating of high-density lipoproteins: relevance to high-density lipoprotein biogenesis

Jayaraman, S., Cavigiolio, G., & Gursky, O. (2011) · Biochemical Journal · doi:10.1042/bj20111831 · Cited by 28

Effects of the Iowa and Milano Mutations on Apolipoprotein A-I Structure and Dynamics Determined by Hydrogen Exchange and Mass Spectrometry

Chetty, P. S., Ohshiro, M., Saito, H., Dhanasekaran, P., Lund‐Katz, S., Mayne, L. C., Englander, W., & Phillips, M. C. (2012) · Biochemistry · doi:10.1021/bi300926j · Cited by 27

Genetically personalised organ-specific metabolic models in health and disease

Foguet, C., Xu, Y., Ritchie, S. C., Lambert, S. A., Persyn, E., Nath, A. P., Davenport, E. E., Roberts, D. J., Paul, D. S., Angelantonio, E. D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35017-7 · Cited by 26

HDL-C: Does it matter? An update on novel HDL-directed pharmaco-therapeutic strategies

Gadi, R., Amanullah, A. M., & Figueredo, V. M. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.05.052 · Cited by 27

Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia

Martinez, L. R. C., Santos, R. D., Miname, M. H., Deus, D. F., Lima, É. S., & Maranhão, R. C. (2013) · Metabolism · doi:10.1016/j.metabol.2013.02.008 · Cited by 27

Prevalence and Correlates of Vitamin D Deficiency and Insufficiency in Luxembourg Adults: Evidence from the Observation of Cardiovascular Risk Factors (ORISCAV-LUX) Study

Alkerwi, A., Sauvageot, N., Gilson, G., & Stranges, S. (2015) · Nutrients · doi:10.3390/nu7085308 · Cited by 27

Proteome profiles of HDL particles of patients with chronic heart failure are associated with immune response and also include bacteria proteins

Oberbach, A., Adams, V., Schlichting, N. S., Heinrich, M., Kullnick, Y., Lehmann, S., Lehmann, S., Feder, S., Correia, J. C., Mohr, F., et al. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.12.005 · Cited by 27

Accelerated atherosclerosis caused by serum amyloid A response in lungs of ApoE −/− mice

Christophersen, D. V., Möller, P., Thomsen, M. B., Lykkesfeldt, J., Loft, S. H., Wallin, H., Vogel, U. B., & Jacobsen, N. R. (2021) · The FASEB Journal · doi:10.1096/fj.202002017r · Cited by 26

LDL Apheresis and Inflammation – Implications for Atherosclerosis

Hovland, A., Lappegård, K. T., & Mollnes, T. E. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02734.x · Cited by 26

A critical appraisal of the measurement of serum ‘cholesterol efflux capacity’ and its use as surrogate marker of risk of cardiovascular disease

Anastasius, M. O., Luquain‐Costaz, C., Kockx, M., Jessup, W., & Kritharides, L. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.08.002 · Cited by 28

History of cardiovascular disease and cardiovascular biomarkers are associated with 30-day mortality in patients with hip fracture

Norring-Agerskov, D., Madsen, C. M., Bathum, L., Pedersen, O. B., Lauritzen, J. B., Jørgensen, N. R., & Jørgensen, H. L. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05056-w · Cited by 25

High density lipoprotein and cardiovascular diseases

Filippatos, T. D. (2013) · World Journal of Cardiology · doi:10.4330/wjc.v5.i7.210 · Cited by 25

High-density lipoprotein therapeutics and cardiovascular prevention

Fazio, S., & Linton, M. F. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.004 · Cited by 26

Apolipoprotein A-I attenuates LL-37-induced endothelial cell cytotoxicity

Svensson, D., Lagerstedt, J. O., Nilsson, B., & Giudice, R. D. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.072 · Cited by 25

Interactions of six SNPs in APOA1 gene and types of obesity on low HDL-C disease in Xinjiang pastoral area of China

Wang, X., He, J., Guo, H., Mu, L., Hu, Y., Ma, J., Yan, Y., Ma, R., Li, S., Ding, Y., et al. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0581-8 · Cited by 25

Novel technique for generating macrophage foam cells for in vitro reverse cholesterol transport studies

Sengupta, B., Narasimhulu, C. A., & Parthasarathy, S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m041327 · Cited by 24

Postpartum Weight Retention is Associated with Elevated Ratio of Oxidized LDL Lipids to HDL‐Cholesterol

Puhkala, J., Luoto, R. M., Ahotupa, M. O., Raitanen, J. A., & Vasankari, T. J. (2013) · Lipids · doi:10.1007/s11745-013-3852-9 · Cited by 24

Secondary Structure Changes in ApoA-I Milano (R173C) Are Not Accompanied by a Decrease in Protein Stability or Solubility

Petrlová, J., Dalla‐Riva, J., Mörgelin, M., Lindahl, M., Krupinska, E., Stenkula, K. G., Voss, J. C., & Lagerstedt, J. O. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096150 · Cited by 24

A pilot study indicating the dysregulation of the complement and coagulation cascades in treated schizophrenia and bipolar disorder patients

Cruz, E. C. S., Zandonadi, F. D. S., Fontes, W., & Sussulini, A. (2021) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2021.140657 · Cited by 25

Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib

Hegele, R. A., & Goldberg (2012) · Drug Design Development and Therapy · doi:10.2147/dddt.s34976 · Cited by 24

Pathophysiology and inhibition of cholesteryl ester transfer protein for prevention of cardiovascular diseases: An update

Banerjee, S., & De, A. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.03.016 · Cited by 22

Apolipoprotein a1 increases mitochondrial biogenesis through AMP-activated protein kinase

Song, P., Kwon, Y., Yea, K., Moon, H. Y., Yoon, J. H., Ghim, J., Hyun, H., Kim, D., Koh, A., Berggren, P., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.05.003 · Cited by 23

Animal Models and the Tumor Microenvironment: Studies of Tumor–Host Symbiosis

Lindner, D. J. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.004 · Cited by 23

Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction

Korjian, S., Kazmi, S. H. A., Chi, G., Kalaycı, A., Lee, J., Talib, U., Wright, S. D., Duffy, D., Kingwell, B. A., Mehran, R., et al. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad014 · Cited by 23

Improvement in High-Density Lipoprotein Cholesterol Levels in Argentine Indian School Children after Vitamin D Supplementation

Hirschler, V., Maccallini, G., Sanchez, M. S., Castaño, L. A., Molinari, C., & on behalf of San Antonio de los Cobres Study Group (2013) · Hormone Research in Paediatrics · doi:10.1159/000355511 · Cited by 21

Low concentrations of phospholipids and plasma HDL cholesterol subclasses in asymptomatic subjects with high coronary calcium scores

García-Sánchez, C., Posadas‐Romero, C., Posadas‐Sánchez, R., Carreón‐Torres, E., Rodrı́guez-Pérez, J. M., Juárez-Rojas, J. G., Martínez‐Sánchez, C., Fragoso, J. M., González‐Pacheco, H., Vargas‐Alarcón, G., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.004 · Cited by 21

Vitamin D: Correlation with biochemical and body composition changes in a southern Brazilian population and induction of cytotoxicity in mesenchymal stem cells derived from human adipose tissue

Pesarini, J. R., Oliveira, R. J., Pessatto, L. R., Antoniolli‐Silva, A. C. M. B., Felicidade, I., Nardi, N. B., Camassola, M., Mantovani, M. S., & Ribeiro, L. R. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.013 · Cited by 21

High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases

Hafiane, A., Favari, E., Daskalopoulou, S. S., Vuilleumier, N., & Frias, M. A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154141 · Cited by 23

Association between alcohol dietary pattern and prevalence of dyslipidaemia: WASEDA’S Health Study

Tanisawa, K., Ito, T., Kawakami, R., Usui, C., Kawamura, T., Suzuki, K., Sakamoto, S., Ishii, K., Muraoka, I., Oka, K., et al. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521002671 · Cited by 20

Inhibitory effects of in vivo oxidized high‐density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia

Calzada, C., Véricel, E., Colas, R. A., Guillot, N., Khoury, G. E., Drai, J., Sassolas, A., Peretti, N., Ponsin, G., Lagarde, M., et al. (2013) · The FASEB Journal · doi:10.1096/fj.12-225169 · Cited by 20

The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta

Battle, S., Gogonea, V., Willard, B. B., Wang, Z., Fu, X., Huang, Y. R., Graham, L. M., Cameron, S. J., DiDonato, J. A., Crabb, J. W., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101832 · Cited by 20

Underappreciated Opportunities for High-Density Lipoprotein Particles in Risk Stratification and Potential Targets of Therapy

Rosenson, R. S., Davidson, M. H., Le, N., Burkle, J., & Pourfarzib, R. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6567-0 · Cited by 21

Genetic Polymorphisms in the APOA1 Gene and their Relationship with Serum HDL Cholesterol Levels

Bandarian, F., Hedayati, M., DANESHPOUR, M. S., Naseri, M., & Azizi, F. (2013) · Lipids · doi:10.1007/s11745-013-3847-6 · Cited by 19

Are Gujarati Asian Indians ‘older’ for their ‘vascular age’ as compared to their ‘Chronological age’?

Sharma, K. H., Sahoo, S., Shah, K. H., Patel, A. K., Jadhav, N., Parmar, M., & Patel, K. (2014) · QJM · doi:10.1093/qjmed/hcu158 · Cited by 19

Surface behavior of apolipoprotein A-I and its deletion mutants at model lipoprotein interfaces

Wang, L., Mei, X., Atkinson, D., & SMALL, D. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m044743 · Cited by 19

Postprandial Studies Uncover Differing Effects on HDL Particles of Overt and Subclinical Hypothyroidism

McGowan, A., Widdowson, W. M., O’Regan, A., Young, I. S., Boran, G. P., McEneny, J., & Gibney, J. (2016) · Thyroid · doi:10.1089/thy.2015.0443 · Cited by 19

Characterization of reconstituted high-density lipoprotein particles formed by lipid interactions with human serum amyloid A

Takase, H., Furuchi, H., Tanaka, M., Yamada, T., Matoba, K., Iwasaki, K., Kawakami, T., & Mukai, T. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.07.012 · Cited by 19

Serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein B, and coronary heart disease in a Chinese population undergoing coronary angiography

Ling, Y., Jiang, J., Wu, B., & Gao, X. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.02.017 · Cited by 19

ApoA-1 accelerates regeneration of small-for-size fatty liver graft after transplantation

Li, C. X., Chen, L., Li, X. C., Ng, T., Yang, X. X., Lo, C. M., Guan, X., & Man, K. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.10.053 · Cited by 19

Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives

Teixeira, P. C., Cutler, P., & Vuilleumier, N. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/868251 · Cited by 18

HDL (High-Density Lipoprotein) Subspecies, Prevalent Covert Brain Infarcts, and Incident Overt Ischemic Stroke: Cardiovascular Health Study

Koch, M., Aroner, S. A., Fitzpatrick, A. L., Longstreth, W. T., Furtado, J. D., Mukamal, K. J., & Jensen, M. K. (2021) · Stroke · doi:10.1161/strokeaha.121.034299 · Cited by 18

HDL-cholesterol concentration and its association with coronary artery calcification: a systematic review and meta-analysis

Abedi, F., Sadeghi, M., Omidkhoda, N., Kelesidis, T., Ramezani, J., Samadi, S., & Mohammadpour, A. H. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01827-x · Cited by 18

Metabolic Syndrome: An Overview on Its Genetic Associations and Gene–Diet Interactions

Prone-Olazábal, D., Davies, I. G., & González-Galarza, F. F. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0125 · Cited by 19

Association between organophosphate flame retardant exposure and lipid metabolism: data from the 2013–2014 National Health and Nutrition Examination Survey

Cheng, F., Tsai, K., Huang, K., Kung, C., Huang, W., You, H., Li, S.-H., Wang, C., Lee, W., & Pan, H.-Y. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1340261 · Cited by 18

The secondary structure of apolipoprotein A ‐ I on 9.6‐nm reconstituted high‐density lipoprotein determined by EPR spectroscopy

Oda, M. N., Budamagunta, M. S., Borja, M. S., Petrlová, J., Voss, J. C., & Lagerstedt, J. O. (2013) · FEBS Journal · doi:10.1111/febs.12334 · Cited by 18

Association of the APOA1 rs964184 SNP and serum lipid traits in the Chinese Maonan and Han populations

Qiu, L., Yin, R., Khounphinith, E., Zhang, F.-H., Yang, D.-Z., & Pan, S. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0759-8 · Cited by 18

Genetic and Non-Genetic Factor-Adjusted Association between Coffee Drinking and High-Density Lipoprotein Cholesterol in Taiwanese Adults: Stratification by Sex

Hsu, T., Tantoh, D. M., Lee, K.-J., Nfor, O. N., Lin, L., Chou, M., & Liaw, Y. (2019) · Nutrients · doi:10.3390/nu11051102 · Cited by 17

Update on HDL Receptors and Cellular Cholesterol Transport

Kellner-Weibel, G., & de la Llera-Moya, M. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0169-0 · Cited by 17

Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden

Gebhard, C., Rhainds, D., He, G., Rodés‐Cabau, J., Lavi, S., Spence, J. D., Title, L. M., Kouz, S., L’Allier, P. L., Grégoire, J. C., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.025 · Cited by 17

The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage

White, C. R., Datta, G., Wilson, L. S., Palgunachari, M. N., & Anantharamaiah, G. M. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.01.009 · Cited by 17

The promise of apolipoprotein A-I mimetics

Mendez, A. J. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283373cb5 · Cited by 17

HDL as a Treatment Target: Should We Abandon This Idea?

Bègue, F., Apalama, M. L., Lambert, G. C., & Meilhac, O. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01176-1 · Cited by 16

High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis

Cheng, W., Rosołowski, M., Boettner, J., Desch, S., Jobs, A., Thiele, H., & Buttner, P. G. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01657-3 · Cited by 16

The Srb1+1050T Allele Is Associated with Metabolic Syndrome in Children but Not with Cholesteryl Ester Plasma Concentrations of High-Density Lipoprotein Subclasses

Juárez-Meavepeña, M., Carreón‐Torres, E., López-Osorio, C., García-Sánchez, C., Gamboa, R., Torres‐Tamayo, M., Fragoso, J. M., Rodrı́guez-Pérez, J. M., Vargas‐Alarcón, G., & Pérez-Méndez, O. A. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0071 · Cited by 16

Structural and Functional Analysis of the ApolipoproteinA-I A164S Variant

Dalla‐Riva, J., Lagerstedt, J. O., & Petrlová, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143915 · Cited by 16

Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL

Cao, P., Pan, H., Xiao, T., Zhou, T., Guo, J., & Su, Z. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817245 · Cited by 15

Metabolic Syndrome and Cardiometabolic Risk Factors in the Mixed Hypercholesterolemic Populations with Respect to Gender, Age, and Obesity in Asir, Saudi Arabia

Ahmed, A. E., AlSamghan, A. S., Momenah, M. A., Alqhtani, H. A., Aldawood, N. A., Alshehri, M. A., Alshehri, A. A., Alhag, S. K., Mosaad, Y. O., & Ahmed, H. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192214985 · Cited by 15

Effect of Bariatric Surgery on High-Density Lipoprotein (HDL) Cholesterol in Non-diabetic Patients with Severe Obesity

Nienov, O. H., Machado, F. D., Dias, L. S., Carli, L. A. D., & Schmid, H. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04126-6 · Cited by 15

EPR assessment of protein sites for incorporation of Gd(III) MRI contrast labels

Lagerstedt, J. O., Petrlová, J., Hilt, S., Marek, A., Chung, Y., Sriram, R., Budamagunta, M. S., Desreux, J. F., Thonon, D., Jue, T., et al. (2013) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1518 · Cited by 14

Beneficial effects of a new probiotic formulation on adipocytokines, appetite-regulating hormones, and metabolic parameters in obese women

Okuka, N., Milinković, N., Veličković, K., Polovina, S. P., Šumarac-Dumanović, M., Minić, R., Korčok, D., Djordjevic, B. I., & Ivanović, N. (2024) · Food & Function · doi:10.1039/d4fo01269k · Cited by 13

Use of Expert Consensus to Improve Atherogenic Dyslipidemia Management

Núñez-Cortés, J. M., Pedro‐Botet, J., Brea-Hernando, Á., Rodríguez, Á. D., González‐Santos, P., Hernández‐Mijares, A., Mantilla, T., Pintó, X., & Simó, R. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.06.011 · Cited by 12

Cholesteryl Ester Transfer Protein Inhibitors as Agents to Reduce Coronary Heart Disease Risk

Barter, P. J., & Rye, K. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2017.12.011 · Cited by 12

The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE Study

Colombo, G. I., Bianconi, V., Bonomi, A., Simonelli, S., Amato, M., Frigerio, B., Ravani, A. L., Vitali, C., Sansaro, D., Coggi, D., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9030286 · Cited by 12

Rapid Decrease in HDL-C in the Puberty Period of Boys Associated with an Elevation of Blood Pressure and Dyslipidemia in Korean Teenagers: An Explanation of Why and When Men Have Lower HDL-C Levels Than Women

Cho, K., & Kim, J. (2021) · Medical Sciences · doi:10.3390/medsci9020035 · Cited by 14

Lipoprotein glycation in atherogenesis

Younis, N. N., Soran, H., Sharma, R., Charlton-Menys, V., & Durrington, P. N. (2009) · Clinical Lipidology · doi:10.2217/clp.09.61 · Cited by 12

Dislipidemia aterogénica y riesgo residual. Estado de la cuestión en 2014

Núñez-Cortés, J. M., Pedro‐Botet, J., & Pintó, X. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.09.004 · Cited by 11

Atherosclerotic cardiovascular disease in hyperalphalipoproteinemia due to LIPG variants

Cole, J., Blackhurst, D. M., Solomon, G. A. E., Ratanjee, B. D., Benjamin, R. L., & Marais, A. D. (2020) · Journal of clinical lipidology · doi:10.1016/j.jacl.2020.12.007 · Cited by 11

Sida acuta leaf extract attenuates oxidants-induced animal model of nephrotoxicity and hepatotoxicity

Ogunmoyole, T., Falusi, O. O., & Oderinde, F. (2022) · Clinical Phytoscience · doi:10.1186/s40816-021-00336-7 · Cited by 10

Dietary ω3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study

Padró, T., López‐Yerena, A., Pérez, A., Vilahur, G., & Badimón, L. (2023) · Nutrients · doi:10.3390/nu15163637 · Cited by 11

Pressure Perturbation Calorimetry of Lipoproteins Reveals an Endothermic Transition without Detectable Volume Changes. Implications for Adsorption of Apolipoprotein to a Phospholipid Surface

Jayaraman, S., Jasuja, R., Zakharov, M. N., & Gursky, O. (2011) · Biochemistry · doi:10.1021/bi200090y · Cited by 11

Distinct roles of size-defined HDL subpopulations in cardiovascular disease

Davidson, W. S., Vaisar, T., Heinecke, J. W., & Bornfeldt, K. (2024) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000959 · Cited by 10

Underperforming doctors in general practice: a survey of referrals to UK Deaneries.

Bahrami, J., & Evans, A. (2001) · Europe PMC (PubMed Central) · Cited by 10

HDL3-C is a Marker of Coronary Artery Disease Severity and Inflammation in Patients on Statin Therapy

Chaudhary, R., Kinderytė, M., Chaudhary, R., Sukhi, A., Bliden, K. P., Tantry, U. S., & Gurbel, P. A. (2018) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2018.12.019 · Cited by 10

New evidences on the association between high-density lipoprotein cholesterol and cardiovascular risk: a never ending research story

Fogacci, F., Borghi, C., & Cicero, A. F. G. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac015 · Cited by 10

Association between the atherogenic index of plasma and major adverse cardiovascular events in individuals with metabolic syndrome: findings from the UK biobank

Yuanjia, H., Li, W., Nie, J., Zhang, C., Zhou, J. Y., Hu, Z., Zhou, H., & Lei, X. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-03010-1 · Cited by 10

Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial

Toth, P. P., Jones, S. R., Slee, A. E., Fleg, J. L., Marcovina, S. M., Lacy, M., McBride, R., & Boden, W. E. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.03.077 · Cited by 9

Association of Platelet-Monocyte Ratio with Dyslipidemia in Saudi Arabia: A Large, Population-Based Study

Alfhili, M. A., Alotaibi, G. A., Alfaifi, M. A., Almoghrabi, Y. M., & Alsughayyir, J. (2023) · Life · doi:10.3390/life13081685 · Cited by 9

Atorvastatin and fenofibrate combination induces the predominance of the large HDL subclasses and increased apo AI fractional catabolic rates in N ew Z ealand white rabbits with exogenous hypercholesterolemia

Flores‐Castillo, C., Zamora‐Pérez, J. Á., Carreón‐Torres, E., Arzola‐Paniagua, A., Aguilar-Salinas, C. A., López‐Olmos, V., Fragoso, J. M., Luna‐Luna, M., Rodrı́guez-Pérez, J. M., Franco, M., et al. (2015) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12125 · Cited by 9

Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence

Raut, S., Garud, A., Nagarajan, B., Sabnis, N. A., Remaley, A. T., Fudala, R., Gryczyński, I., Gryczynski, Z. K., Dzyuba, S. V., Borejdo, J., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.262899 · Cited by 9

Simultaneous Noninvasive Detection and Therapy of Atherosclerosis Using HDL Coated Gold Nanorods

Ankri, R., Leshem‐Lev, D., Duadi, H., Harari, E., Motiei, M., Hochhauser, E., Lev, E. I., & Fixler, D. (2022) · Diagnostics · doi:10.3390/diagnostics12030577 · Cited by 9

Genes associated with low serum high-density lipoprotein cholesterol.

Ahmadzadeh, A., & Azizi, F. (2014) · PubMed · Cited by 9

Brain Control of Plasma Cholesterol Involves Polysialic Acid Molecules in the Hypothalamus

Brénachot, X., Gautier, T., Nédélec, E., Deckert, V., Laderrière, A., Nuzzaci, D., Rigault, C., Lemoine, A., Pénicaud, L., Lagrost, L., et al. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00245 · Cited by 9

Biological activities of HDL subpopulations and their relevance to cardiovascular disease

Camont, L., Chapman, M. J., & Kontush, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.05.013 · Cited by 484

Regulation of High-Density Lipoprotein Metabolism

Rye, K., & Barter, P. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.300632 · Cited by 128

Functionality of HDL particles: Heterogeneity and relationships to cardiovascular disease

Camont, L., Chapman, J., & Kontush, A. (2011) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(11)70784-4 · Cited by 8

Cardioprotective functions of HDLs

Rye, K., & Barter, P. J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r039297 · Cited by 310

Predictive value of different HDL particles for the protection against or risk of coronary heart disease

Rye, K., & Barter, P. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.012 · Cited by 36